Cefprozil Articles
SOBI gains distribution rights for Megace, Monopril, Cefzil and Duricef from PharmaSwiss
13 February 2013
Final US OK for Ranbaxy's cefprozil
22 December 2006
B-MS To Acquire Korean Pharma Firm
28 October 1998
B-MS Cefprozil In Spain
6 August 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
"Solid Growth" At Bristol-Myers Squibb
5 May 1997
B-MS Gains Rights For Eisai Antifungal
23 December 1996
Bristol-Myers Squibb Has "Best Combo Of Businesses"
20 February 1995
CURRENCIES STILL A FACTOR IN US 1st QTR
2 May 1994
STRONG DOLLAR WEAKENS US 1993 RESULTS
31 January 1994
US 3rd QTR AFFECTED BY STRONG DOLLAR
1 November 1993
NEW CHEMICAL ENTITIES LAUNCHED IN 1992
1 February 1993
STRONG INCREASES IN 1991 AT BRISTOL-MYERS SQUIBB
20 April 1992
NEW CHEMICAL ENTITIES UPDATE FOR 1991
10 February 1992
DECEMBER US APPROS REVIEWED
20 January 1992
US FDA BEATS 1990 DRUG APPROVALS IN 1991
13 January 1992
Showing 1-17 of 17 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
